• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于大米的口服霍乱疫苗可诱导猕猴特异性全身中和抗体,但不影响已有的肠道免疫力。

A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.

作者信息

Nochi Tomonori, Yuki Yoshikazu, Katakai Yuko, Shibata Hiroaki, Tokuhara Daisuke, Mejima Mio, Kurokawa Shiho, Takahashi Yuko, Nakanishi Ushio, Ono Fumiko, Mimuro Hitomi, Sasakawa Chihiro, Takaiwa Fumio, Terao Keiji, Kiyono Hiroshi

机构信息

Division of Mucosal Immunology, Department of Microbiology and Immunology, University of Tokyo, Japan.

出版信息

J Immunol. 2009 Nov 15;183(10):6538-44. doi: 10.4049/jimmunol.0901480. Epub 2009 Oct 30.

DOI:10.4049/jimmunol.0901480
PMID:19880451
Abstract

We previously showed that oral immunization of mice with a rice-based vaccine expressing cholera toxin (CT) B subunit (MucoRice-CT-B) induced CT-specific immune responses with toxin-neutralizing activity in both systemic and mucosal compartments. In this study, we examined whether the vaccine can induce CT-specific Ab responses in nonhuman primates. Orally administered MucoRice-CT-B induced high levels of CT-neutralizing serum IgG Abs in the three cynomolgus macaques we immunized. Although the Ab level gradually decreased, detectable levels were maintained for at least 6 mo, and high titers were rapidly recovered after an oral booster dose of the rice-based vaccine. In contrast, no serum IgE Abs against rice storage protein were induced even after multiple immunizations. Additionally, before immunization the macaques harbored intestinal secretory IgA (SIgA) Abs that reacted with both CT and homologous heat-labile enterotoxin produced by enterotoxigenic Escherichia coli and had toxin-neutralizing activity. The SIgA Abs were present in macaques 1 mo to 29 years old, and the level was not enhanced after oral vaccination with MucoRice-CT-B or after subsequent oral administration of the native form of CT. These results show that oral MucoRice-CT-B can effectively induce CT-specific, neutralizing, serum IgG Ab responses even in the presence of pre-existing CT- and heat-labile enterotoxin-reactive intestinal SIgA Abs in nonhuman primates.

摘要

我们之前的研究表明,用表达霍乱毒素(CT)B亚基的水稻疫苗(MucoRice-CT-B)对小鼠进行口服免疫,可在全身和黏膜部位诱导产生具有毒素中和活性的CT特异性免疫反应。在本研究中,我们检测了该疫苗能否在非人灵长类动物中诱导CT特异性抗体反应。口服MucoRice-CT-B在我们免疫的三只食蟹猴中诱导产生了高水平的CT中和血清IgG抗体。尽管抗体水平逐渐下降,但可检测水平至少维持了6个月,口服一剂水稻疫苗加强免疫后,高滴度抗体迅速恢复。相比之下,即使多次免疫后也未诱导出针对水稻储存蛋白的血清IgE抗体。此外,在免疫前,食蟹猴体内存在与CT以及产肠毒素大肠杆菌产生的同源不耐热肠毒素均发生反应且具有毒素中和活性的肠道分泌型IgA(SIgA)抗体。SIgA抗体存在于1月龄至29岁的食蟹猴中,在用MucoRice-CT-B口服疫苗接种后或随后口服天然形式的CT后,其水平并未升高。这些结果表明,即使在非人灵长类动物中预先存在与CT和不耐热肠毒素反应的肠道SIgA抗体的情况下,口服MucoRice-CT-B仍能有效诱导CT特异性、中和性血清IgG抗体反应。

相似文献

1
A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity.一种基于大米的口服霍乱疫苗可诱导猕猴特异性全身中和抗体,但不影响已有的肠道免疫力。
J Immunol. 2009 Nov 15;183(10):6538-44. doi: 10.4049/jimmunol.0901480. Epub 2009 Oct 30.
2
Oral MucoRice expressing double-mutant cholera toxin A and B subunits induces toxin-specific neutralising immunity.表达双突变霍乱毒素A和B亚基的口服MucoRice诱导毒素特异性中和免疫。
Vaccine. 2009 Oct 9;27(43):5982-8. doi: 10.1016/j.vaccine.2009.07.071. Epub 2009 Aug 7.
3
Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine.基于稻米的疫苗通过分泌型免疫球蛋白 A 对霍乱弧菌和产耐热肠毒素的肠致病性大肠杆菌的保护作用。
Proc Natl Acad Sci U S A. 2010 May 11;107(19):8794-9. doi: 10.1073/pnas.0914121107. Epub 2010 Apr 26.
4
Induction of toxin-specific neutralizing immunity by molecularly uniform rice-based oral cholera toxin B subunit vaccine without plant-associated sugar modification.通过分子均一的基于水稻的口服霍乱毒素 B 亚单位疫苗诱导针对毒素的中和免疫,无需植物相关糖修饰。
Plant Biotechnol J. 2013 Sep;11(7):799-808. doi: 10.1111/pbi.12071. Epub 2013 Apr 22.
5
Construction and preclinical evaluation of recombinant Peru-15 expressing high levels of the cholera toxin B subunit as a vaccine against enterotoxigenic Escherichia coli.表达高水平霍乱毒素B亚基的重组秘鲁-15作为抗产肠毒素大肠杆菌疫苗的构建及临床前评估
Vaccine. 2007 Dec 12;25(51):8574-84. doi: 10.1016/j.vaccine.2007.09.074. Epub 2007 Oct 26.
6
Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.口服灭活全细胞重组B亚单位霍乱疫苗在哥伦比亚巴兰基亚的安全性和免疫原性。
Bull Pan Am Health Organ. 1995 Dec;29(4):312-21.
7
Oral immunization with simian immunodeficiency virus p55gag and cholera toxin elicits both mucosal IgA and systemic IgG immune responses in nonhuman primates.用猿猴免疫缺陷病毒p55gag和霍乱毒素进行口服免疫可在非人灵长类动物中引发黏膜IgA和全身性IgG免疫反应。
J Immunol. 1997 Jun 1;158(11):5321-9.
8
Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.用重组毒素调节菌毛和霍乱毒素B亚单位进行鼻内免疫可保护兔子免受霍乱弧菌O1的攻击。
FEMS Immunol Med Microbiol. 2009 Jul;56(2):179-84. doi: 10.1111/j.1574-695X.2009.00563.x. Epub 2009 May 5.
9
Neonatal sublingual vaccination with Salmonella proteins and adjuvant cholera toxin or CpG oligodeoxynucleotides induces mucosal and systemic immunity in mice.用沙门氏菌蛋白及佐剂霍乱毒素或CpG寡脱氧核苷酸对新生小鼠进行舌下接种可诱导小鼠产生黏膜免疫和全身免疫。
J Pediatr Gastroenterol Nutr. 2008 Mar;46(3):262-71. doi: 10.1097/MPG.0b013e318156050d.
10
Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.利用霍乱毒素B亚基作为免疫原、载体和佐剂在黏膜表面诱导免疫反应的策略。
Am J Trop Med Hyg. 1994;50(5 Suppl):42-54.

引用本文的文献

1
A single donor cassette enables site-specific knock-in at either the αAmy3 or αAmy8 locus in rice cells via CRISPR/Cas9.单个供体盒可通过CRISPR/Cas9在水稻细胞中的αAmy3或αAmy8位点实现位点特异性敲入。
Appl Microbiol Biotechnol. 2025 Aug 21;109(1):190. doi: 10.1007/s00253-025-13549-4.
2
, classification, pathogenesis, immune response, and trends in vaccine development.分类、发病机制、免疫反应及疫苗研发趋势。
Front Med (Lausanne). 2023 May 5;10:1155751. doi: 10.3389/fmed.2023.1155751. eCollection 2023.
3
Emerging trends of edible vaccine therapy for combating human diseases especially COVID-19: Pros, cons, and future challenges.
新兴的可食用疫苗疗法用于防治人类疾病(特别是 COVID-19)的趋势:利弊及未来挑战。
Phytother Res. 2022 Jul;36(7):2746-2766. doi: 10.1002/ptr.7475. Epub 2022 May 2.
4
Plant-Based COVID-19 Vaccines: Current Status, Design, and Development Strategies of Candidate Vaccines.基于植物的新冠疫苗:候选疫苗的现状、设计与开发策略
Vaccines (Basel). 2021 Sep 6;9(9):992. doi: 10.3390/vaccines9090992.
5
Mucosal vaccines: wisdom from now and then.黏膜疫苗:今昔智慧。
Int Immunol. 2021 Nov 25;33(12):767-774. doi: 10.1093/intimm/dxab056.
6
Combating Human Viral Diseases: Will Plant-Based Vaccines Be the Answer?对抗人类病毒性疾病:植物源疫苗会是答案吗?
Vaccines (Basel). 2021 Jul 8;9(7):761. doi: 10.3390/vaccines9070761.
7
Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: Affordable drugs in edible plants for endemic and re-emerging diseases.国际植物科学界为人类防治传染病做出的贡献 2:可食用植物中的廉价药物用于防治地方性和再现传染病。
Plant Biotechnol J. 2021 Oct;19(10):1921-1936. doi: 10.1111/pbi.13658. Epub 2021 Jul 19.
8
Cord Blood-Based Approach to Assess Candidate Vaccine Adjuvants Designed for Neonates and Infants.基于脐带血的方法来评估为新生儿和婴儿设计的候选疫苗佐剂。
Vaccines (Basel). 2021 Jan 27;9(2):95. doi: 10.3390/vaccines9020095.
9
A cross talk between the immunization and edible vaccine: Current challenges and future prospects.免疫与食用疫苗的对话:当前挑战与未来展望。
Life Sci. 2020 Nov 15;261:118343. doi: 10.1016/j.lfs.2020.118343. Epub 2020 Aug 26.
10
Edible Vaccines: Promises and Challenges.可食用疫苗:前景与挑战。
Mol Biotechnol. 2020 Feb;62(2):79-90. doi: 10.1007/s12033-019-00222-1.